Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Naylor, K.E."'
Publikováno v:
In Bone February 2020 131
Publikováno v:
In Bone November 2016 92:94-99
Publikováno v:
In Bone March 2010 46(3):592-597
Autor:
Naylor, K.E., McCloskey, E.V., Jacques, R.M., Peel, N.F.A., Paggiosi, M.A., Gossiel, F., Walsh, J.S., Eastell, R.
Summary\ud Bone markers may be useful to monitor response to treatment withdrawal in osteoporosis. We used two criteria for investigating the change in BTMs after withdrawal of bisphosphonate treatment. A larger increase in BTMs was associated with g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f6e55160bc8fe36bce93c64bb3bb841a
https://eprints.whiterose.ac.uk/140995/1/Naylor_et_al-2019-Osteoporosis_International.pdf
https://eprints.whiterose.ac.uk/140995/1/Naylor_et_al-2019-Osteoporosis_International.pdf
Autor:
Naylor, K.E., Bradburn, M., Paggiosi, M.A., Gossiel, F., Peel, N.F.A., McCloskey, E.V., Walsh, J.S., Eastell, R.
Publikováno v:
Osteoporosis International
The antiresorptive potency varies between different bisphosphonates. We investigated the effect of stopping oral bisphosphonate treatment for postmenopausal osteoporosis (ibandronate, alendronate, risedronate) on BTMs and BMD. After stopping treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c30ef5079ffa87a50c90b1f8b35b5cd1
Autor:
Gossiel, F., Scott, J.R., Paggiosi, M.A., Naylor, K.E., McCloskey, E.V., Peel, N.F.A., Walsh, J.S., Eastell, R.
Context: Treatment of postmenopausal osteoporosis with teriparatide (PTH 1-34) increases bone formation and improves bone microarchitecture. A possible modulator of this mechanism of action is periostin. In vitro experiments have shown that periostin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::457e91267765fb40ce36ae205ea1d44c
https://eprints.whiterose.ac.uk/127209/8/jc.2017-00283.pdf
https://eprints.whiterose.ac.uk/127209/8/jc.2017-00283.pdf
Publikováno v:
In BJOG: An International Journal of Obstetrics and Gynaecology 2002 109(7):812-820
Bone turnover markers are useful in clinical practice as they are inexpensive and they have proven useful for treatment monitoring and identification of poor adherence. BTM cannot be used in individual patients for identifying accelerated bone loss o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::54f64154f6f3a99318d6538f357a6df7
https://eprints.whiterose.ac.uk/123286/1/EJE-17-0585.full.pdf
https://eprints.whiterose.ac.uk/123286/1/EJE-17-0585.full.pdf
Autor:
Walsh, J.S., Evans, A.L., Bowles, S., Naylor, K.E., Jones, K.S., Schoenmakers, I., Jacques, R.M., Eastell, R.
Background: The mechanism and clinical significance of low circulating 25-hydroxyvitamin D [25(OH)D] in obese people are unknown. Low total 25(OH)D may be due to low vitamin D–binding proteins (DBPs) or faster metabolic clearance. However, obese pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d834093eb2f8d09e6e503a5fac3d5c62
https://eprints.whiterose.ac.uk/98488/1/R4.docx
https://eprints.whiterose.ac.uk/98488/1/R4.docx
Autor:
Naylor, K.E., Jacques, R.M., Paggiosi, M., Gossiel, F., Peel, N.F., McCloskey, E.V., Walsh, J.S., Eastell, R.
Publikováno v:
Osteoporosis International
We used bone turnover markers to identify women who responded to bisphosphonate treatment for osteoporosis. Response was more likely with alendronate and ibandronate than risedronate. There was a greater decrease in bone markers if baseline bone turn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::8016451b6d5c46e42983a77558873220